TY - BOOK AU - Ferlay, J. AU - Shin, H. R. AU - Bray, F. AU - Forman, D. AU - Mathers, C. AU - Parkin, D. M. PY - 2010 DA - 2010// TI - GLOBOCAN 2008, Cancer Incidence and Mortality Worldwide. IARC CancerBase No. 10 PB - International Agency for Research on Cancer CY - Lyon ID - Ferlay2010 ER - TY - STD TI - Dušek L, Mužík J, Kubásek M, Koptíková J, Zaloudík J, Vyzula R: Epidemiology of malignant tumours in the Czech Republic. [http://www.svod.cz] UR - http://www.svod.cz ID - ref2 ER - TY - JOUR AU - Kopetz, S. AU - Chang, G. J. AU - Overman, M. J. AU - Eng, C. AU - Sargent, D. J. AU - Larson, D. W. AU - Grothey, A. AU - Vauthey, J. N. AU - Nagorney, D. M. AU - McWilliams, R. R. PY - 2009 DA - 2009// TI - Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.20.5278 DO - 10.1200/JCO.2008.20.5278 ID - Kopetz2009 ER - TY - JOUR AU - Peeters, M. AU - Price, T. PY - 2012 DA - 2012// TI - Biologic therapies in the metastatic colorectal cancer treatment continuum–applying current evidence to clinical practice JO - Cancer Treat Rev VL - 38 UR - https://doi.org/10.1016/j.ctrv.2011.08.002 DO - 10.1016/j.ctrv.2011.08.002 ID - Peeters2012 ER - TY - JOUR AU - Hurwitz, H. AU - Fehrenbacher, L. AU - Novotny, W. AU - Cartwright, T. AU - Hainsworth, J. AU - Heim, W. AU - Berlin, J. AU - Baron, A. AU - Griffing, S. AU - Holmgren, E. AU - Ferrara, N. AU - Fyfe, G. AU - Rogers, B. AU - Ross, R. AU - Kabbinavar, F. PY - 2004 DA - 2004// TI - Bevacizumab plus irinotecan, fluorouracil and leucovorin for metastatic colorectal cancer JO - N Engl J Med VL - 250 UR - https://doi.org/10.1056/NEJMoa032691 DO - 10.1056/NEJMoa032691 ID - Hurwitz2004 ER - TY - JOUR AU - Kabbinavar, F. F. AU - Hambleton, J. AU - Mass, R. D. AU - Hurwitz, H. I. AU - Bergsland, E. AU - Sarkar, S. PY - 2005 DA - 2005// TI - Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival in patiens with metastatic colorectal cancer JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.00.232 DO - 10.1200/JCO.2005.00.232 ID - Kabbinavar2005 ER - TY - JOUR AU - Saltz, L. B. AU - Clarke, S. AU - Díaz-Rubio, E. AU - Scheithauer, W. AU - Figer, A. AU - Wong, R. AU - Koski, S. AU - Lichinitser, M. AU - Yang, T. S. AU - Rivera, F. AU - Couture, F. AU - Sirzén, F. AU - Cassidy, J. PY - 2013–2019 DA - 2013–2019// TI - Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer: a randomized phase III study JO - J Clin Oncol VL - 2008 ID - Saltz2013–2019 ER - TY - JOUR AU - Kozloff, M. AU - Yood, M. U. AU - Berlin, J. AU - Flynn, P. J. AU - Kabbinavar, F. F. AU - Purdie, D. M. AU - Ashby, M. A. AU - Dong, W. AU - Sugrue, M. M. AU - Grothey, A. PY - 2009 DA - 2009// TI - Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study JO - Oncologist VL - 14 UR - https://doi.org/10.1634/theoncologist.2009-0071 DO - 10.1634/theoncologist.2009-0071 ID - Kozloff2009 ER - TY - JOUR AU - Van Cutsem, E. AU - Rivera, F. AU - Berry, S. AU - Kretzschmar, A. AU - Michael, M. AU - DiBartolomeo, M. AU - Mazier, M. A. AU - Canon, J. L. AU - Georgoulias, V. AU - Peeters, M. AU - Bridgewater, J. PY - 1842–1847 DA - 1842–1847// TI - Safety and efficacy of first-line bevacizumab with FOLFOX, XELOX, FOLFIRI and fluoropyrimidines in metastatic colorectal cancer: the BEAT study JO - Ann Oncol VL - 2009 ID - Van Cutsem1842–1847 ER - TY - JOUR AU - Hutchins, L. F. AU - Unger, J. M. AU - Crowley, J. J. AU - Coltman, C. A. AU - Albain, K. S. PY - 2061–2067 DA - 2061–2067// TI - Underrepresentation of patients 65 years of age or older in cancer-treatment trials JO - N Engl J Med VL - 1999 ID - Hutchins2061–2067 ER - TY - BOOK AU - Dusek, L. PY - 2009 DA - 2009// TI - Czech Cancer Care in Numbers 2008–2009 PB - Grada Publishing CY - Prague ID - Dusek2009 ER - TY - JOUR AU - Kabbinavar, F. F. AU - Hurwitz, H. I. AU - Yi, J. AU - Sarkar, S. AU - Rosen, O. PY - 2009 DA - 2009// TI - Addition of bevacizumab to fluorouracil-based first-line treatment of metastatic colorectal cancer: pooled analysis of cohorts of older patients from two randomized clinical trials JO - J Clin Oncol VL - 27 UR - https://doi.org/10.1200/JCO.2008.17.7931 DO - 10.1200/JCO.2008.17.7931 ID - Kabbinavar2009 ER - TY - JOUR AU - Cassidy, J. AU - Saltz, L. B. AU - Giantonio, B. J. AU - Kabbinavar, F. F. AU - Hurwitz, H. I. AU - Rohr, U. P. PY - 2010 DA - 2010// TI - Effect of bevacizumab in older patients with metastatic colorectal cancer: pooled analysis of four randomized studies JO - J Cancer Res Clin Oncol VL - 136 UR - https://doi.org/10.1007/s00432-009-0712-3 DO - 10.1007/s00432-009-0712-3 ID - Cassidy2010 ER - TY - JOUR AU - Price, T. J. AU - Zannino, D. AU - Wilson, K. AU - Simes, R. J. AU - Cassidy, J. AU - Van Hazel, G. A. AU - Robinson, B. A. AU - Broad, A. AU - Ganju, V. AU - Ackland, S. P. AU - Tebbutt, N. C. PY - 2012 DA - 2012// TI - Bevacizumab is equally effective and no more toxic in elderly patients with advanced colorectal cancer: a subgroup analysis from the AGITG MAX trial: an international randomised controlled trial of Capecitabine, Bevacizumab and Mitomycin C JO - Ann Oncol VL - 23 UR - https://doi.org/10.1093/annonc/mdr488 DO - 10.1093/annonc/mdr488 ID - Price2012 ER - TY - JOUR AU - Kozloff, M. F. AU - Berlin, J. AU - Flynn, P. J. AU - Kabbinavar, F. AU - Ashby, M. AU - Dong, W. AU - Sing, A. P. AU - Grothey, A. PY - 2010 DA - 2010// TI - Clinical outcomes in elderly patients with metastatic colorectal cancer receiving bevacizumab and chemotherapy: results from the BRiTE observational cohort study JO - Oncology VL - 78 UR - https://doi.org/10.1159/000320222 DO - 10.1159/000320222 ID - Kozloff2010 ER - TY - JOUR AU - Němeček, R. AU - Tomášek, J. AU - Hejduk, K. AU - Bortlíček, Z. PY - 2012 DA - 2012// TI - Klinický registr CORECT JO - Klin onkol VL - 25 ID - Němeček2012 ER - TY - JOUR AU - Goldberg, R. M. AU - Tabah-Fisch, I. AU - Bleiberg, H. AU - de Gramont, A. AU - Tournigand, C. AU - Andre, T. AU - Rothenberg, M. L. AU - Green, E. AU - Sargent, D. J. PY - 2006 DA - 2006// TI - Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2006.06.9039 DO - 10.1200/JCO.2006.06.9039 ID - Goldberg2006 ER - TY - JOUR AU - Cunningham, D. AU - Lang, I. AU - Marcuello, E. AU - Lorusso, V. AU - Ocvirk, J. AU - Shin, D. B. AU - Jonker, D. AU - Osborne, S. AU - Andre, N. AU - Waterkamp, D. AU - Saunders, M. P. PY - 2013 DA - 2013// TI - Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial JO - Lancet Oncol VL - 14 UR - https://doi.org/10.1016/S1470-2045(13)70154-2 DO - 10.1016/S1470-2045(13)70154-2 ID - Cunningham2013 ER - TY - JOUR AU - Meyerhardt, J. A. AU - Li, L. AU - Sanoff, H. K. AU - Carpenter, W. AU - Schrag, D. PY - 2012 DA - 2012// TI - Effectiveness of bevacizumab with first-line combination chemotherapy for Medicare patients with stage IV colorectal cancer JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.9650 DO - 10.1200/JCO.2011.38.9650 ID - Meyerhardt2012 ER - TY - JOUR AU - Zhu, X. AU - Wu, S. AU - Dahut, W. L. AU - Parikh, C. R. PY - 2007 DA - 2007// TI - Risks of proteinuria and hypertension with bevacizumab, an antibody against vascular endothelial growth factor: systematic review and meta-analysis JO - Am J Kidney Dis VL - 49 UR - https://doi.org/10.1053/j.ajkd.2006.11.039 DO - 10.1053/j.ajkd.2006.11.039 ID - Zhu2007 ER - TY - JOUR AU - Tsai, H. T. AU - Marshall, J. L. AU - Weiss, S. R. AU - Huang, C. Y. AU - Warren, J. L. AU - Freedman, A. N. AU - Fu, A. Z. AU - Sansbury, L. B. AU - Potosky, A. L. PY - 2013 DA - 2013// TI - Bevacizumab use and risk of cardiovascular adverse events among elderly patients with colorectal cancer receiving chemotherapy: a population-based study JO - Ann Oncol VL - 24 UR - https://doi.org/10.1093/annonc/mdt019 DO - 10.1093/annonc/mdt019 ID - Tsai2013 ER - TY - JOUR AU - Aprile, G. AU - Ferrari, L. AU - Fontanella, C. AU - Puglisi, F. PY - 2013 DA - 2013// TI - Bevacizumab in older patients with advanced colorectal or breast cancer JO - Crit Rev Oncol/Hematol VL - 87 UR - https://doi.org/10.1016/j.critrevonc.2012.11.006 DO - 10.1016/j.critrevonc.2012.11.006 ID - Aprile2013 ER - TY - JOUR AU - Kyriakou, F. AU - Kountourakis, P. AU - Papamichael, D. PY - 2011 DA - 2011// TI - Targeted agents: review of toxicity in the elderly metastatic colorectal cancer patients JO - Target Oncol VL - 6 UR - https://doi.org/10.1007/s11523-011-0198-1 DO - 10.1007/s11523-011-0198-1 ID - Kyriakou2011 ER - TY - JOUR AU - Pavlík, T. AU - Májek, O. AU - Büchler, T. AU - Vyzula, R. AU - Petera, J. AU - Ryska, M. AU - Ryška, A. AU - Cibula, D. AU - Babjuk, M. AU - Abrahámová, J. AU - Vorlíček, J. AU - Mužík, J. AU - Dušek, L. PY - 2014 DA - 2014// TI - Trends in stage-specific population-based survival of cancer patients in the Czech Republic in the period 2000–2008 JO - Cancer Epidemiol VL - 38 UR - https://doi.org/10.1016/j.canep.2013.11.002 DO - 10.1016/j.canep.2013.11.002 ID - Pavlík2014 ER - TY - JOUR AU - Brenner, H. AU - Gondos, A. AU - Arndt, V. PY - 2007 DA - 2007// TI - Recent major progress in long-term cancer patient survival disclosed by modeled period analysis JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.11.3431 DO - 10.1200/JCO.2007.11.3431 ID - Brenner2007 ER - TY - STD TI - Allemani C, Rachet B, Weir HK, Richardson LC, Lepage C, Faivre J, Gatta G, Capocaccia R, Sant M, Baili P, Lombardo C, Aareleid T, Ardanaz E, Bielska-Lasota M, Bolick S, Cress R, Elferink M, Fulton JP, Galceran J, Gózdz S, Hakulinen T, Primic-Zakelj M, Rachtan J, Diba CS, Sánchez MJ, Schymura MJ, Shen T, Tagliabue G, Tumino R, Vercelli M, et al: Colorectal cancer survival in the USA and Europe: a CONCORD high-resolution study. BMJ Open. in press ID - ref26 ER - TY - STD TI - The pre-publication history for this paper can be accessed here:http://www.biomedcentral.com/1471-230X/14/53/prepub UR - http://www.biomedcentral.com/1471-230X/14/53/prepub ID - ref27 ER -